Suppr超能文献

核因子-κB 通路对小鼠脊髓运动神经元中存活运动神经元蛋白的调节作用。

Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.

机构信息

Unitat de Senyalització Neuronal, Dep. Medicina Experimental, Universitat de Lleida-IRBLLEIDA, Rovira Roure 80, 25198, Lleida, Spain.

出版信息

Mol Neurobiol. 2018 Jun;55(6):5019-5030. doi: 10.1007/s12035-017-0710-4. Epub 2017 Aug 14.

Abstract

Survival motor neuron (SMN) protein deficiency causes the genetic neuromuscular disorder spinal muscular atrophy (SMA), characterized by spinal cord motoneuron degeneration. Since SMN protein level is critical to disease onset and severity, analysis of the mechanisms involved in SMN stability is one of the central goals of SMA research. Here, we describe the role of several members of the NF-κB pathway in regulating SMN in motoneurons. NF-κB is one of the main regulators of motoneuron survival and pharmacological inhibition of NF-κB pathway activity also induces mouse survival motor neuron (Smn) protein decrease. Using a lentiviral-based shRNA approach to reduce the expression of several members of NF-κB pathway, we observed that IKK and RelA knockdown caused Smn reduction in mouse-cultured motoneurons whereas IKK or RelB knockdown did not. Moreover, isolated motoneurons obtained from the severe SMA mouse model showed reduced protein levels of several NF-κB members and RelA phosphorylation. We describe the alteration of NF-κB pathway in SMA cells. In the context of recent studies suggesting regulation of altered intracellular pathways as a future pharmacological treatment of SMA, we propose the NF-κB pathway as a candidate in this new therapeutic approach.

摘要

生存运动神经元 (SMN) 蛋白缺乏会导致遗传性神经肌肉疾病脊髓性肌萎缩症 (SMA),其特征是脊髓运动神经元退化。由于 SMN 蛋白水平对疾病的发生和严重程度至关重要,因此分析参与 SMN 稳定性的机制是 SMA 研究的核心目标之一。在这里,我们描述了 NF-κB 通路的几个成员在调节运动神经元中的 SMN 中的作用。NF-κB 是运动神经元存活的主要调节剂之一,NF-κB 通路活性的药理学抑制也会诱导小鼠生存运动神经元 (Smn) 蛋白减少。使用基于慢病毒的 shRNA 方法来降低 NF-κB 通路的几个成员的表达,我们观察到 IKK 和 RelA 的敲低导致培养的小鼠运动神经元中的 Smn 减少,而 IKK 或 RelB 的敲低则没有。此外,从严重的 SMA 小鼠模型中分离出的运动神经元表现出几种 NF-κB 成员的蛋白水平降低和 RelA 磷酸化。我们描述了 SMA 细胞中 NF-κB 通路的改变。在最近的研究表明,作为 SMA 的未来药物治疗,调节改变的细胞内途径的建议的背景下,我们提出 NF-κB 途径作为这种新的治疗方法的候选者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验